Chronic Lyme Recovery After 30 Years
An anonymized clinical case demonstrating that even patients with decades-long chronic Lyme disease and concurrent COVID-related complications can respond to comprehensive multimodal treatment.
Patient Profile
Age: 50s
Gender: Female
Country: United States
Disease Duration: 30+ years
Treatment Date: 2024
Follow-Up: 12 months
All identifying details have been anonymized. This case study is published with the patient’s family’s consent.
Prior Treatment History
This patient had been living with chronic Lyme disease for more than three decades. Over that time, she had undergone numerous treatment attempts, including:
- Multiple extended courses of oral and IV antibiotics prescribed by Lyme-literate physicians in the United States
- Various herbal antimicrobial protocols (Byron White formulas, Buhner protocol, and others)
- Nutritional and detoxification programs
- Functional medicine approaches addressing mold toxicity, gut health, and immune support
While some of these treatments provided temporary symptom relief, none had produced lasting improvement. The patient described her condition as a cycle of modest gains followed by inevitable relapse, a pattern that had persisted for years.
Presentation at St. George Hospital
At the time of her initial consultation, the patient presented with the following symptoms and findings:
- Severe fatigue — Persistent exhaustion limiting daily activities, unresponsive to rest
- Cognitive dysfunction — Significant brain fog, difficulty concentrating, word-finding difficulties
- Joint and muscle pain — Migratory pain affecting multiple joints, chronic muscle aches
- Immune compromise — Recurrent infections, slow recovery from minor illness
- COVID-related complications — Following COVID vaccination, the patient developed new symptoms including clotting abnormalities and worsened fatigue, suggesting COVID-related vascular and inflammatory complications overlaying her existing Lyme disease
Diagnostic Findings
Comprehensive diagnostic testing at St. George Hospital revealed:
- Positive Borrelia ELISpot — Confirming active cellular immune response to Borrelia antigens, indicating persistent infection
- Depressed CD57+ NK cells — A hallmark of chronic Borrelia infection, indicating ongoing immune suppression
- Elevated inflammatory markers — CRP, cytokines, and other inflammatory parameters above normal ranges
- COVID-related clotting markers — Elevated D-dimer and fibrinogen levels, along with evidence of endothelial dysfunction, consistent with COVID-related vascular pathology
- Co-infection markers — Evidence suggestive of concurrent co-infection requiring additional targeted treatment
The diagnostic picture confirmed a complex case: chronic Lyme disease with persistent Borrelia infection, overlaid with COVID-related vascular and inflammatory complications. Both conditions required targeted intervention.
Comprehensive diagnostic testing at St. George Hospital revealed:
Treatment Protocol
The patient received the Lyme Eradication Package (2 weeks inpatient) as the foundation of her treatment. The protocol was developed by Dr. Julian Douwes, Chief Medical Officer, and supervised by the Lyme disease treatment team.
Lyme-Targeted Treatment
- 2 whole-body hyperthermia sessions at 41.6–41.8 °C for 120 minutes each
- 2 weeks combination IV antibiotics targeting all Borrelia morphological forms
- Detoxification infusions (glutathione, alpha-lipoic acid)
- Immune support (high-dose IV vitamin C, micronutrients)
- Daily physical therapy and lymphatic drainage
COVID-Related Protocol
- H.E.L.P. apheresis sessions to address elevated fibrinogen and clotting abnormalities
- Anti-inflammatory protocols targeting endothelial dysfunction
- Microcirculation support
- Treatment coordinated with Dr. Beate Jaeger's Post-COVID expertise
Clinical Outcomes
At 3 Months Post-Treatment
- Energy levels noticeably improving, with increased capacity for daily activities
- Sleep quality improving, less interrupted sleep
- Immune markers showing early signs of normalization
- Clotting parameters improving toward normal ranges
- Cognitive function beginning to improve, with reduced brain fog episodes
At 12 Months Post-Treatment
“I am so much better and still improving every day.”
— Patient, 12 months post-treatment
- Sustained improvement in energy, cognitive function, and overall quality of life
- Continued positive trajectory — improvement ongoing rather than plateau
- Immune markers continuing to normalize on follow-up testing
- No return of the relapse pattern that had characterized the previous 30 years
Key Takeaways
- Disease duration does not preclude response to treatment. Even after 30 years of chronic Lyme disease, this patient responded to a comprehensive multimodal approach that addressed the infection, immune dysfunction, and inflammatory burden simultaneously.
- Concurrent conditions must be identified and treated. The overlay of COVID-related vascular complications on chronic Lyme disease required parallel treatment protocols. Addressing only one condition would have produced incomplete results.
- Single-modality treatment is insufficient for complex cases. This patient had tried antibiotics, herbals, and functional medicine approaches individually over 30 years. The multimodal integration of hyperthermia, antibiotics, apheresis, immune support, and detoxification delivered together in a structured inpatient program produced the first sustained improvement.
- Recovery is a process. The patient’s continued improvement at 12 months underscores that treatment initiates a healing trajectory rather than producing an instantaneous cure. Structured follow-up and ongoing support are essential.